Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea. (Q35905142)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

title

Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

Hee Chul Shin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

11

In Gab Jeong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

9

Hwang Gyun Jeon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Sung Han Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

Sung Ja Chang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

Sooin Yun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

Jungnam Joo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

Ja Hyeon Ku

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

Hyung Suk Kim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

Byong Chang Jeong

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

Seok Ho Kang

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

Bumsik Hong

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

UCART (urothelial cancer-advanced research and treatment group in Korea) group

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

publication date

15 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

Journal of Korean Medical Science

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

1150-1156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma

20 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

International variations in bladder cancer incidence and mortality.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Efficacy of Bladder-Preserving Therapy for Patients with T3b, T4a, and T4b Transitional Cell Carcinoma of the Bladder

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

The 2004 WHO classification of bladder tumors: a summary and commentary

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Perioperative chemotherapy in advanced bladder cancer: part I. Neoadjuvant treatment

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Prediction of cancer incidence and mortality in Korea, 2014.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapy.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogate.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Perioperative chemotherapy in muscle-invasive bladder cancer: overview and the unmet clinical need for alternative adjuvant therapy as studied in the MAGNOLIA trial

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Neo-adjuvant chemotherapy for invasive bladder cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4520947

Perioperative chemotherapy for muscle-invasive bladder cancer: A population-based outcomes study

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26240494

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3346/JKMS.2015.30.8.1150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

26240494

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26240494 AND SRC:MED&resulttype=core&format=json